Researchers still found 'excellent' survival rates for both primary, secondary disease
SUNDAY, Dec. 8, 2013 (HealthDay News) -- Preliminary research shows that gene therapy might one day be a powerful weapon against leukemia and other blood cancers.
The experimental treatment coaxed certain blood cells into targeting and destroying cancer cells, according to research presented this weekend at the American Society of Hematology's annual meeting in New Orleans.
"It's really exciting," Dr. Janis Abkowitz, blood diseases chief at the University of Washington in Seattle and president of the American Society of Hematology, told the Associated Press. "You can take a cell that belongs to a patient and engineer it to be an attack cell."
At this point, more than 120 patients with different types of blood and bone marrow cancers have been given the treatment, according to the wire service, and many have gone into remission and stayed in remission up to three years later.
In one study, all five adults and 19 of 22 children with acute lymphocytic leukemia (ALL) were cleared of the cancer. A few have relapsed since the study was done.
In another trial, 15 of 32 patients with chronic lymphocytic leukemia (CLL) initially responded to the therapy and seven have experienced a complete remission of their disease, according to a news release from the trial researchers, who are from the University of Pennsylvania.
All the patients in the studies had few options left, the researchers noted in the news release. Many were ineligible for bone marrow transplantation or did not want that treatment because of the dangers associated with the procedure, which carries at least a 20 percent mortality risk.
The gene therapy could become a much needed alternative for those with blood cancers.
"Our findings show that the human immune system and these modified 'hunter' cells are working together to attack tumors in an entirely new way," research leader Dr. Carl June, professor in immunotherapy in the department of pathology and laboratory medicine and director of translational research at Penn's Abramson Cancer Center, said in the news release.
Penn researchers have treated the most patients, 59, with this gene therapy. Scientists at the U.S. National Cancer Institute, Memorial Sloan-Kettering Cancer Center in New York City, and the University of Texas MD Anderson Cancer Center and Baylor University in Houston have treated smaller groups of patients, according to the AP.
In the studies, researchers filtered the patients' blood, removing white blood cells known as T-cells that are part of the body's immune system. They then added a gene to the T-cells that would target cancer cells. The altered T-cells were returned to the patients' body in infusions that were given over the course of three days.
Several companies are developing these types of cancer therapies, and a clinical trial next year could lead to federal approval of the treatment by 2016, the AP reported.
"From our vantage point, this looks like a major advance," Lee Greenberger, chief scientific officer of the Leukemia and Lymphoma Society, told the AP. "We are seeing powerful responses... and time will tell how enduring these remissions turn out to be."
The gene therapy must be made individually for each patient, and lab costs now are about $25,000, without a profit margin, the AP reported.
The treatment can cause severe flu-like symptoms and other side effects, but these have been reversible and temporary, doctors said.
For more on leukemia and lymphoma, visit the Leukemia and Lymphoma Society.
SOURCES: University of Pennsylvania, news release, Dec. 7, 2013; Associated Press
Copyright © 2013 HealthDay. All rights reserved.
Fri Dec 13, 2013 09:43 PM
I have smoldering Myeloma and will be going though an NK infusion trial in early Jan. at UAMS under Dr. Van Rhees direction. If anyone has interest in following my progress you may email me at email@example.com or call 954.591.5355 EST before 8 PM. Steve Arnold
Fri Dec 13, 2013 11:38 PM
Sun Dec 15, 2013 10:37 PM
Hi i have multiple myeloma iga its been 2.5 yrs of so many different chemo druges i say to my hemok i am sick and tired of feeling sick and tired . I have just been put on pomalyst and my doc said this drug is a miracle worker taking my #s from 1200 to 350 for the first time ever. but feeling sick and tired! I have been told there is no relief i am destined to take these killer chemo drugs for the rest of my life 7 yrs? im hoping this new gene therapy will earn the drug companies enuf monies to push their use ,on another note i have found Dr Linus pauling and i have found the use of high dose vit. c has given me a feeling of well being and relief of the feeling of sick and tired i suggest you try it john firstname.lastname@example.org
We care about your feedback. Let us know how we can improve your CancerCompass experience.